PRESS RELEASE published on 08/24/2026 at 08:05, 2 months 4 days ago TME Pharma provides update on its activities TME Pharma provides update on its activities including final evaluation phase with potential partners for NOX-A12, with estimated peak sales potential of $1 billion, strategic decision framework, and scientific validation Clinical-stage Biotechnology License Agreement TME Pharma NOX-A12 Brain Cancer
PRESS RELEASE published on 08/24/2026 at 08:05, 2 months 4 days ago TME Pharma fait le point sur ses activités TME Pharma fait le point sur ses activités et les négociations pour un accord de licence pour NOX-A12, médicament phare pour le cancer du cerveau. Analyse stratégique en cours Biotechnologie Accord De Licence TME Pharma NOX-A12 Cancer Du Cerveau
BRIEF published on 10/30/2025 at 21:05, 11 months 28 days ago TME Pharma's Semi-Annual Report and Financial Restructuring Financial Results Biotechnology CEO Appointment Bond Issuance TME Pharma
BRIEF published on 10/30/2025 at 21:05, 11 months 28 days ago Rapport semestriel et restructuration financière de TME Pharma Résultats Financiers Biotechnologie Emission D'obligations Nomination Du PDG TME Pharma
PRESS RELEASE published on 10/30/2025 at 21:00, 11 months 28 days ago TME Pharma publishes its semi annual results and half-year report TME Pharma publishes semi annual results and half-year report showing cost reductions, new CEO, and fundraising activities. Focus on NOX-A12 and NOX-E36 assets Fundraising Cost Reductions TME Pharma NOX-A12 Semi Annual Results
PRESS RELEASE published on 09/01/2025 at 08:45, 1 year 1 month ago Inside Information: Other news releases TME Pharma completes August financing, with €500k cash received on August 28th, bringing cash position to €2.35M. Organization aims to attract financing for cancer and eye therapies Cash Position TME Pharma August Financing Cost-efficient Organization Novel Therapies
BRIEF published on 09/01/2025 at 08:45, 1 year 1 month ago TME Pharma conclut avec succès sa levée de fonds d'août Biotechnologie Trésorerie Levée De Fonds Cryptomonnaies Cancer
BRIEF published on 09/01/2025 at 08:45, 1 year 1 month ago TME Pharma successfully completes its August fundraising round Biotechnology Fundraising Treasury Cryptocurrencies Cancer
PRESS RELEASE published on 09/01/2025 at 08:40, 1 year 1 month ago Informations privilégiées:Autres communiqués TME Pharma finalise une levée de fonds de 500 k € en espèces en août, atteignant une trésorerie de 2,35 M € pour développer de nouvelles thérapies contre le cancer et les maladies oculaires Trésorerie Levée De Fonds Cancer TME Pharma Thérapies
BRIEF published on 08/25/2025 at 08:05, 1 year 2 months ago TME Pharma Secures €500,000 through New Bond Issue Investment Strategy Cost Reduction Bond Issuance Financial Strategy Shareholder Commitments
Published on 10/28/2026 at 08:00, 46 minutes ago Algo Grande Copper Makes New Skarn Discovery at Adelita; Step-Out Hole AG-CG-PH2-003 Returns a Combined 139.81 Metres of 1.3% CuEq from Cerro Grande and the New Margarita Skarn
Published on 10/28/2026 at 02:55, 5 hours 51 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 5 hours 56 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 9 hours 6 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 9 hours 21 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/28/2026 at 08:05, 41 minutes ago CookieYes Earns Built for Shopify Badge for Its Cookie Consent App
Published on 10/28/2026 at 08:00, 46 minutes ago Coinsilium Group Limited: Portfolio Ventures: Strategic and Commercial Update
Published on 10/28/2026 at 08:00, 46 minutes ago TRATON GROUP increases unit sales, sales revenue, and adjusted operating result in the first nine months of 2026
Published on 10/28/2026 at 08:00, 46 minutes ago Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/28/2026 at 08:00, 46 minutes ago Edenred lève avec succès 800 millions d’euros dans le cadre d’une émission obligataire à deux tranches
Published on 10/27/2026 at 18:00, 14 hours 46 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 14 hours 46 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
